Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adoring: Tapinarof Cream in Pediatric Atopic Dermatitis
NCT07265479Phase 3Suspended
- Sponsor
- Organon & Co.
- Start
- Dec 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tapinarof in atopic dermatitis (AD), sponsored by Organon & Co.. Started Dec 2025; status: suspended.
02
Drugs
tapinarof
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07265479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07265479.